J.L. Geiger

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “18 FDG PET/CT prediction of treatment outcomes in patients with p16-positive, non-smoking associated, locoregionally advanced oropharyngeal cancer (LA-OPC) receiving deintensified therapy: Results from NRG-HN002.”.

18 FDG PET/CT prediction of treatment outcomes in patients with p16-positive, non-smoking associated, locoregionally advanced oropharyngeal cancer (LA-OPC) receiving deintensified therapy: Results from NRG-HN002.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6563

N/A

0.208DataRank · unranked

3 citations

Lyudmila DeMora, Min Yao, Sue S. Yom, Maura L. Gillison, Jimmy J. Caudell +15 more

Association of plasma tumor tissue modified viral HPV DNA (TTMV) with tumor burden, treatment type, and outcome: A translational analysis from NRG-HN002.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6006

N/A

0DataRank · unranked

12 citations

Pedro A. Torres‐Saavedra, Charlotte Kuperwasser, Sunil Kumar, Piyush B. Gupta, Patrick K. Ha +12 more